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Pathogenesise viral gene expression in ganglia without laborious histological sectioning and
staining, we created a two color ﬂuorescent recombinant HSV-1, in which enhanced green ﬂuorescent
protein (EGFP) and red ﬂuorescent protein (RFP) are expressed from the glycoprotein B (gB) and glycoprotein
C (gC) promoters respectively. We show that this virus retained growth and pathogenic capacity both in vitro
and in vivo compared to wild type HSV-1; established latent infections with similar genome copy number in
trigeminal ganglia (TG); induced a similar HSV-speciﬁc CD8+ T cell inﬁltrate; did not induce CD8+ T cells
reactive to EGFP or RFP; and reactivated from latency with normal kinetics in ex vivo TG cultures. Fluorescent
EGFP expression in plaques surrounding neurons preceded RFP expression and provided highly sensitive
detection of reactivation and different stages of infection in ex vivo TG cultures. Expression of both EGFP and
RFP in neurons was readily detectable in whole mounts of TG excised during acute infection and following
in vivo sodium butyrate-induced reactivation from latency. This virus constitutes a useful reagent for
monitoring lytic viral promoter activity in sensory neurons in vivo and in vitro.
© 2008 Elsevier Inc. All rights reserved.IntroductionHerpes simplex virus type 1 (HSV-1) adopts two modes of infection
in humans and in animal models: a productive lytic infection and a
latent infection in which the viral genome can persist for prolonged
periods without virion formation. Lytic infections occur in most non-
neuronal cell types and involve the coordinated and highly regulated
temporal expression of approximately 80 viral genes to yield progeny
virus. Temporal phases of viral gene expression can be experimentally
deﬁned into at least four classes. The immediate early (IE orα) genes are
transcribed ﬁrst without requiring de novo protein synthesis. The
transcription of early (E or β) and late (L or γ) genes requires the
expression of functional α proteins. Maximal β gene transcription rates
occur prior to viral DNA replication, whereas γ gene transcription peaks
only after DNA replication has initiated. The γ genes are sub-classiﬁed
into γ1 and γ2; γ1 gene expression can occur prior to viral DNA
synthesis, while γ2 gene expression absolutely requires initiation of
viral DNA synthesis (Honess and Roizman, 1974). The γ1 genes includeogy, and Molecular Microbiol-
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l rights reserved.glycoprotein gB, an essential glycoprotein which is an important
immunogenic target of adaptive immunity in humans and animal
models (Khanna et al., 2003; Zarling et al., 1986). Even though gB is a γ1
gene, recent studies have shown gB expression at very early stages (2 h)
of viral infection and have demonstrated it to be an early immunological
target (Mueller et al., 2003).
In the well-characterized murine animal model of HSV-1 corneal
infection following scariﬁcation, virus undergoes a short productive
replication in the corneal epithelium that enables access of infectious
virions to the termini of sensory neurons that innervate the cornea.
Virions travel by retrograde axonal transport to the neuronal nuclei
within the ophthalmic branch of the trigeminal ganglion (TG), where
viral genomes enter a latent state. Productive infection in the TG is
limited by innate immunity, may amplify the viral load and permit
lateral spread to surrounding neurons (Kodukula et al., 1999;
Margolis et al., 1992). Latency in neurons is accompanied by silencing
of most lytic protein expression and restriction of most transcription,
except that from the non-protein-encoding latency-associated trans-
cripts (LATs). LAT-speciﬁc expression is largely through the modula-
tion of heterochromatin on the latent genome and shielding of the
LAT region by chromatin insulators (Amelio, McAnany, and Bloom,
2006; Wang et al., 2005). Latency enables HSV-1 to coexist with the
host for prolonged periods with the capacity to intermittently
reactivate from latency leading to recurrent disease and transmission
to new hosts.
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silent state ignored by the host immune system has now changed to
one in which sporadic antigenic expression occurs, permitting
immune surveillance of latently infected neurons (Decman et al.,
2005a). Like many other herpesviruses, HSV-1 expresses a limited
array of lytic proteins in the context of a latent infection in the murine
model, even though spontaneous viral reactivation from latency has
rarely been detected at the periphery. Recent studies have now in-
dicated that spontaneous reactivation leading to viral gene expression
and even infectious virus in the TG can occur in some mice strains
(Margolis et al., 2007). Both transcripts and proteins of multiple
kinetic classes have been detected in latently infected ganglia in-
cluding infected cell protein 4 (ICP4, α), thymidine kinase (TK, β) and
gC (γ2) (Feldman et al., 2002). Expression may occur in the TG in the
apparent absence of infectious virus production (Feldman et al., 2002;
Kramer and Coen, 1995). This either represents normal viral gene
expression during rare aborted or contained spontaneous reactivation
events, or may represent isolated gene expression events outside of
the accepted kinetics of the lytic cascade (Tal-Singer et al., 1997). Low
or intermittent lytic protein expression during latency correlates with
the retention andmaintenance of an activated HSV-speciﬁc CD8+ Tcell
population in latently infected TG in close apposition to latently in-
fected neurons, in both mouse and human TG (Hufner et al., 2006;
Khanna et al., 2003; Theil et al., 2003; Verjans et al., 2007). The
activated phenotype of these cells is not shared by their counterparts
in non-infected tissue such as the lungs or spleen (Hufner et al., 2006;
Khanna et al., 2003; Verjans et al., 2007), further supporting persistent
or sporadic antigen expression and presentation in the context of
MHC-I on neurons.
Several HSV-1 recombinants expressing reporter genes from viral
promoters have been developed to detect viral lytic gene expression.
These viruses have incorporated Escherichia coli LacZ and ﬁreﬂy
luciferase reporters to detect viral gene expression in situ (Hendricks
et al., 1991; Luker et al., 2002). Such reagents are also potentially
useful for examining lytic gene expression during HSV-1 reactivation
from latency in situ or in ex vivo ganglionic cultures. A signiﬁcant
disadvantage of these methods is that their detection requires sub-
strate cofactors or extensive tissue processing. Moreover, the long
term stability of β-galactosidase may errantly indicate persistent gene
expression in a transcriptionally silenced environment (Lachmann
and Efstathiou, 1997). We previously employed a recombinant HSV-1
expressing EGFP, driven by either the ICP0 or gC promoter, to track
viral gene expression during ocular infection and reactivation fromFig. 1. Construction of HSV-1 RE-pgB-EGFP/pgC-RFP virus. A) Representation of the pgC-EGFP
the rest of the gC open reading frame (gC ORF). The ‘s’ at the end of EGFP denotes the stop co
subsequent construct is shown inwhich the gB promoter (pgB) was inserted at the BamHI an
mRFPwas inserted at the NheI and BamHI sites so as to be driven by the gC promoter. D) Repr
the HSV-1 RE genome at the UL44 locus.latency in explanted TG (Decman et al., 2005b). While providing
detection of viral gene expression at the level of sensitivity of real-
time RT-PCR (Decman et al., 2005b), these viruses were limited to
detection of activity of a single viral promoter. Here, we describe the
construction of a novel dual ﬂuorescent reporter HSV-1 recombinant
that permits simultaneous detection of gene expression from two
different kinetic classes of viral promoters within single infected cells
including neurons.
Results
Development of a recombinant dual ﬂuorescent HSV-1
Single ﬂuorescent reporters driven by viral promoters in HSV-1
were detailed previously for the study of pathogenesis (Balliet et al.,
2007; Decman et al., 2005b). These enabled rapid assessment of viral
gene expression and growth, but were limited to single viral temporal
classes of promoters. We were interested in developing viruses
capable of assessing gene expression at the single-cell level. We
developed a virus in which the expression of two temporal classes of
viral promoters could be simultaneously assessed using two ﬂuor-
escent genes (Fig. 1). The virus was derived using a plasmid that
contained a DNA fragment of the sequences upstream of the gB ATG.
This plasmid was placed in the polylinker of pEGFP-N1 to drive EGFP
expression in a manner similar to that used to derive HSV-1 in which
the ICP0 or gC promoter controlled EGFP expression (Fig. 1B) (Decman
et al., 2005b). The plasmid also contained the RFP gene immediately
downstream of the gC promoter but upstream of the gB promoter
(Fig. 1C). Recombinant virus (pgB/pgC) was derived through homo-
logous recombination between the ﬂanking gC sequences and the gC
gene in the HSV-1 RE genome to contain the insertion of the two genes
in the non-essential gC gene, placing the RFP gene under the control of
the native gC promoter at its native site and same direction (Fig. 1D).
The RFP gene contained eight amino acids of gC fused to its N-
terminus. EGFP expression is directed by the inserted upstream gB
promoter sequences and is translationally stopped before the rest of
the gC ORF. Thus gC is not expressed in this virus (data not shown).
RNAs for both ﬂuorescent genes are in the same direction as the native
gC transcript and are presumably terminated by the native gC
polyadenylation motif downstream. While the two RNAs share the
same polyadenylation signal, this is a common occurrence in HSV-1.
The recombinant virus could readily be differentiated from wild
type virus using ﬂuorescencemicroscopy, and virus was isolated usingconstruct, in which expression of EGFP is driven by the gC promoter (pgC), followed by
don. Restriction sites referred to in the text are also indicated below the diagram. B) The
d HindIII sites in EGFP in order to drive EGFP expression. C) The ﬁnal construct in which
esentation of the recombinant virus showing the ﬁnal plasmid that was recombined into
Fig. 3. Multistep viral replication kinetics. Monolayer cultures of Vero cells were
infected at an MOI of 0.01 PFU/cell with HSV-1 RE or pgB/pgC. At the indicated hours
post-infection (h.p.i), cells and supernatants were harvested, pooled, subjected to three
freeze–thaw cycles and the viral titers were determined. The results are shown as mean
numbers of PFU/culture±standard error of the means (SEM). Viral yields were not
signiﬁcantly different (pN0.05) at any time tested as assessed by a Student's t test,
suggesting similar rates of replication.
256 S. Ramachandran et al. / Virology 378 (2008) 254–264excitation ﬁlters to illuminate RFP signals to minimize UV-induced
DNA damage. Correct insertion and disruption of the gC gene was
conﬁrmed using Southern blotting and western blotting for gC ex-
pression (data not shown).
Analysis of HSV-1 protein and RNA transcript kinetics in vitro
The gB promoter was chosen as it is expressed very early during
infection, even though it is classiﬁed as a leaky-late (γ1) gene, whereas
gC is a true-late (γ2) gene that requires DNA replication for
transcription. As such, EGFP expression was expected to occur in the
presence of DNA replication inhibitors, while RFP expression should be
restricted. Comparisons of EGFP and RFP proteins expressed from cells
infected with pgB/pgC to native gB and gC protein expression from
HSV-1 RE are shown in Fig. 2A. Both EGFP and gBwere expressed by 8 h
after high multiplicity infection, whereas gC and RFP were not
efﬁciently detected until 12 h post-infection. Both EGFP in the
recombinant virus and gB in RE were detected in the presence of the
DNA replication inhibitor, phosphonoacetic acid (PAA). Neither gene
was expressed in the presence of cycloheximide (CHX) or following a
cycloheximide reversal by actinomycin-D (AD), establishing that the
genes were not errantly transcribed in the absence of de novo viralFig. 2. Kinetics of viral protein and RNA transcript expression in vitro. Vero cell
monolayers were infected at an MOI of 10 PFU/cell with HSV-1 RE or the pgB/pgC
recombinant. The drug treatments (150 μg/ml cycloheximide, CHX; 15 μg/ml
actinomycin-D, AD; 350 μg/ml phosphonoacetic acid, PAA) and the times of harvest
post-infection, shown in hours, are detailed at the top of each ﬁgure part. A) Proteins
were harvested and analyzed by immunoblotting for EGFP, RFP, gB, and gC expression
using speciﬁc antibodies detailed in Materials and methods and indicated to the right of
the ﬁgure. The top two blots show expression from the pgB/pgC dual ﬂuorescent virus,
whereas the bottom blots show a parallel infection with RE. Coomassie brilliant blue
(CBB) staining was performed for RE to show equal loading of samples in individual
lanes. B) RNA from pgB/pgC-infected cells was analyzed by northern blot using DNA
probes speciﬁc to EGFP and RFP. Autoradiographs for each ﬂuorescent gene were
normalized at the 12 h time point to enable the relative levels of gene expression at
earlier times and in the presence of PAA to be compared.protein synthesis. Expression of RFP and gC was blocked by PAA,
cycloheximide, and after cycloheximide reversal, consistent with true-
late gene expression. We also assessed expression of EGFP and RFP
RNAs (Fig. 2B). RFP and EGFP transcripts were of the size expected for
RNAs terminating at the polyadenylation site downstream of the gC
gene, with the EGFP transcript being smaller, as expected from its
initiation downstream of the RFP gene. While EGFP mRNA could be
detected as soon as 6 h post-infection, RFP mRNAwas barely visible at
8 h post-infection. More importantly, levels of EGFP mRNA were
detected in the presence of PAA, while no RFP transcripts were seen in
the presence of PAA. While the exposure level of the northern blotsFig. 4. Viral titers in tear ﬁlms and TG of infected mice. Mice were infected with HSV-1
RE or pgB/pgC at 1×105 PFU/eye. A) Eye swabs were obtained at the indicated days post-
infection (d.p.i) and titered on Vero cells. The viral titers are shown as means± standard
error of the means (SEM). B) TG were excised, homogenized and subjected to three
freeze–thaw cycles prior to determination of viral titers. Titers of the two viruses in eye
swabs or TG were not signiﬁcantly different (pN0.05) at any time point as assessed by a
Student's t test.
Fig. 5. HSV-1 genome copy number in latently infected TG. TG were obtained 33–
36 days after corneal infection with WT HSV-1 RE or pgB/pgC. Each data point
represents the number of gH DNA copies per TG as determined by real-time PCR
analysis of puriﬁed TG DNA. Data are combined from two independent experiments.
The difference in HSV-1 genome copy number between WT HSV-1 RE and the
recombinant is not signiﬁcant as assessed by Student's t test (p≥0.05).
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overexposure of RFP-probed northerns did not reveal any RFP
transcripts in PAA-treated samples. Quantiﬁcation of autoradiographs
exposed in the linear range of the ﬁlm indicated that PAA reduced the
EGFP transcripts to 36% of the untreated control at 12 h, whereas PAA
reduced RFP transcripts to 2% of the untreated control. These data
would be expected for a DNA replication-facilitated and a DNA
replication-dependent expression, respectively, and establish that
RFP and EGFP expression are regulated differentially as predicted
from their true-late and leaky-late promoters.Fig. 6. Immune inﬁltrate in latently infected TG. TG were obtained 33–34 days after
corneal infection with either pgB/pgC or HSV-1 RE, dispersed with collagenase, stained
for CD45, CD8, and gB498–505 -speciﬁc T cell receptor, and analyzed by ﬂow cytometry.
A) Representative dot plots show separated populations of total CD8+ T cells (circled,
left plot), and CD8+ gB498–505 H2-Kb tetramer+ (gB Tet) T cells (circled, right plot). B)
Data are presented as the mean±SEM of the total numbers of CD8+ T cells/TG or the
total number of gB-speciﬁc CD8+ T cells/TG. Data are pooled from two independent
experiments with n≥8 TG for all conditions. The p values were obtained with a
Student's t test comparing the number of cells in TG infected with WT or pgB/pgC.In vitro growth kinetics
Replication of the recombinant viruswas compared towild type RE
in a multi-step growth curve in Vero cells infected at MOI of 0.01. Peak
titers of virus progeny were observed at 24 h post-infection for both
wild type and recombinant viruses (Fig. 3), and the difference in mean
titers was not statistically signiﬁcant (pN0.05) at any time points
tested. Thus, the recombinant virus does not appear to be growth
impaired in Vero cells.
Viral replication and spread in mice
Because the recombinant virus is defective in the expression of gC,
and some reports have suggested that replication of gC-null viruses
may be attenuated in mouse models (Lubinski et al., 2002), we
assessed in vivo growth in infected corneas and TG of C57Bl/6 mice
following topical corneal infection. Titers of both wild type and
recombinant viruses peaked in the tear ﬁlm at 1 day post-infection (d.
p.i) and decreased over time at rates which did not differ statistically
(Fig. 4A). Similarly, peak TG titers of pgB/pgC and HSV-1 RE (observed
at 4 d.p.i) did not differ signiﬁcantly (Fig. 4B). Both viruseswere largely
eradicated from the TG by 8 d.p.i (Fig. 4B), although a low level of
residual virus (both HSV-1 RE and pgB/pgC) could be recovered from
somemice. These data indicate the recombinant virus exhibits normal
corneal virulence and neurovirulence in mice.
Viral load and CD8+ T cell inﬁltrates within latently infected TG
Previous reports have established the capacity of CD8+ T cells
speciﬁc for the immunodominant gB(498–505) epitope to inhibit HSV-1
reactivation from latency both in vivo and in ex vivo TG cultures of
C57BL/6 mice (Freeman et al., 2007; Khanna et al., 2003; Liu et al.,
2000b; Orr et al., 2007). Another recent report has demonstrated that
HSV-1 reactivation frequency in ex vivo TG cultures is determined byFig. 7. Antigen speciﬁcity of CD8+ T cells in latently infected TG. TG were obtained 8 days
after corneal infectionwith pgB/pgC, dispersed with collagenase, and stimulated for 6 h
with syngeneic B6WT3 cells that were mock transfected or transfected with plasmids
expressing gB, EGFP, or RFP. Cells were surface stained for CD45 and CD8, and stained for
intracellular IFN-γ. Representative dot plots show cells that were gated on CD45 and
analyzed for expression of CD8 and IFN-γ. The graph depicts the mean percent of IFN-γ
positive cells (n=2/group) and standard error of the mean for each stimulation. The
IFN-γ response of gB stimulated CD8+ T cells is signiﬁcantly (pb0.05) different from the
response of the other three groups as assessed by an ANOVA with Tukey's post-test.
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(Hoshino et al., 2007). Therefore, we compared the parameters of CD8+
Tcell inﬁltrate and ganglionic viral load in C57BL/6 TG harboring latent
pgB/pgC to those harboring WT HSV-1 RE following parallel corneal
infections. Quantitative real-time PCR assessment of viral genome
copy number in the TG obtained 33–36 days after HSV-1 corneal
infection with recombinant and WT virus was statistically identical
(Fig. 5). Moreover, neither the size of the overall CD8+ T cell pool, nor
the size of the HSV-speciﬁc CD8+ T cell pool varied signiﬁcantly in TG
colonized by the pgB/pgC or WT RE (Fig. 6).
RE-pgB/pgC does not induce a CD8+ T cell response to EGFP or RFP in
C57Bl/6 mice
EGFP expressing vectors can induce CD8+ T cell responses to EGFP
in BALB/c mice (A Gambotto et al., 2000). Such reactivity could alter
the response of CD8+ T cells to target cells infected with recombinant
viruses that express ﬂuorescent proteins. Therefore, we investigated
the possible immunogenicity of EGFP and RFP proteins expressed fromFig. 8. Detection of viral promoter activity in ex vivoTG cultures by ﬂuorescence microscopy.
with collagenase, and cultured (0.2 TG/well) at 37 °C. A) Images of pgB/pgC-infected TG cultu
BF, brightﬁeld. B) At the indicated times following culture initiation, HSV-1 reactivation fro
ﬁbroblasts (pgB/pgC-infected TG), and on the presence of infectious virus in culture supern
latency and standard error of the mean is shown at each time point. Based on a survival curv
when assessed by ﬂuorescence or plaque assay; nor was the reactivation frequency of pgB/pg
assessed by plaque assay.pgB/pgC virus. For these studies, gB, EGFP, or RFP was expressed from
plasmids under the control of the CMV IE promoter in B6WT3 cells.
Expression of transfected proteins was conﬁrmed by western blot or
ﬂuorescence microscopy (data not shown). Transfected or untreated
cells were used to stimulate IFN-γ production by CD8+ T cells within
dispersed C57BL/6 TG harboring latent pgB/pgC (Fig. 7). Only gB-
transfected cells induced a signiﬁcant IFN-γ response. Thus, pgB/pgC
does not induce a CD8+ T cell response to EGFP or RFP that is
detectable in the latently infected TG.
RE-pgB/pgC reactivates normally in ex vivo TG cultures
Fluorescent protein expression in neurons and surrounding
ﬁbroblasts has previously enabled rapid assessment of HSV-1
reactivation from latency in ex vivo TG cultures (Decman et al.,
2005b). The pgB/pgC virus was designed to offer the advantage of
being able to distinguish expression of the γ1 gB promoter from
expression of the γ2 gC promoter within the same cell. Examination
of ex vivo cultures of TG latently infected with pgB/pgC at lowTG were excised 32–47 days after corneal infectionwith HSV-1 RE or pgB/pgC, dispersed
res were acquired at the indicated times following culture initiation. Magniﬁcation, 10×;
m latency was detected based on spread of ﬂuorescence from neurons to surrounding
atants (plaque assay). The mean percent of cultures exhibiting HSV-1 reactivation from
e analysis the reactivation frequency of pgB/pgC was not signiﬁcantly different (pN0.05)
C as detected by either method signiﬁcantly different (pN0.05) than that of HSV-1 RE as
259S. Ramachandran et al. / Virology 378 (2008) 254–264magniﬁcation revealed ﬂuorescent plaques that initially expressed
only EGFP, but then expressed both EGFP and RFP by day 4 (Fig. 8A).
RFP expression could be detected at earlier stages (2 days post-explant;
d.p.e), but this required higher magniﬁcation and more intense UV
exposure, and we were concerned for the effects on culture viability.
These studies establish that the dual ﬂuorescent virus reactivates from
latency, and that gB and gC promoters are temporally regulated
following reactivation. We then compared the reactivation kinetics
within TG latently infected with either pgB/pgC or WT HSV-1 RE.
Dispersed cells from TG harboring recombinant or wild type latent
virus were cultured, and reactivation was determined by sequential
analysis of supernatant ﬂuids for infectious virus using a standard viral
plaque assay. Reactivation frequencies as determined by either spread
of ﬂuorescence or infectious virus in culture supernatants were nearly
identical for recombinant and wild type viruses (Fig. 8B).
To insure that reactivating pgB/pgC did not revert to wild type
during latency, supernatant ﬂuids from reactivated TG cultures were
added to Vero cell monolayers and developing plaques were
monitored with a ﬂuorescence microscope. As illustrated in Fig. 9, gB
promoter-driven EGFP ﬂuorescence was easily detected in single or
small foci of indicator cells by 24 h in culture, and gC promoter-driven
RFP was ﬁrst detected in Vero cells by 30 h in culture. The extended
time to detect ﬂuorescent gene expression as compared to the kinetic
studies detailed in Fig. 2A reﬂects the requirement for sufﬁcient
amounts of both proteins to accumulate to enable detection following
presumably much lower multiplicities of infection from viral reactiva-
tion. However, all cells ultimately expressed both promoters, and no
non-ﬂuorescent plaques were observed, demonstrating that reversion
to wild type virus did not occur within latently infected neurons.
Confocal imaging of ﬂuorescent gene expression in TG during acute
infection and induced reactivation
We next used the dual ﬂuorescent virus in whole mounts of TG
tissue to image viral gene expression in situ. Both EGFP and RFPFig. 9. Detection of viral promoter activity within pgB/pgC-infected Vero cells by ﬂuorescence
pgC was placed on monolayers of Vero cells and incubated at 37 °C. Images were acquiredexpression were consistently detected in whole mounts of TG that
were excised at 4 d.p.i (Fig. 10B). Fluorescence was detected in both
neurons and non-neuronal cells, and was restricted to the ophthalmic
branch of the TG (not shown). The coexpression of EGFP and RFP
indicated that lytic gene expression from both γ1 and γ2 was ongoing
in these neurons. Fluorescence was not detected in non-infected TG
(Fig. 10A). While not conducted in the same study, examination of TG
whole mounts from HSV-1 RE (non-ﬂuorescent) infected mice did not
reveal any ﬂuorescence at acute or latent time points.
We then explored viral promoter expression in the TG following
the induction of reactivation with sodium butyrate, a histone
deacetylase inhibitor that has recently been shown to efﬁciently
induce HSV-1 reactivation from latency (Neumann et al., 2007).
Within three days post-intraperitoneal injection of a non-lethal dose
of sodium butyrate, several regions of the ganglia contained multiple
neurons expressing both EGFP and RFP, as detected in TG whole
mounts (Figs. 10E and F). The numbers of these EGFP and RFP regions
varied from 1 to 5, suggesting that several neurons in local regions of
the TG were undergoing reactivation and lytic gene expression. High
magniﬁcation revealed punctate speckles of ﬂuorescence that was
restricted to neuronal cell bodies (Fig. 10F). In two separate studies
involving 8 mice each, 100% of mice showed dual ﬂuorescent protein
expression. Fluorescent gene expression was never detected in the
maxillary or mandibular branches of the TG, consistent with the
presence of latent genomes being restricted to the ocular branch, as
previously reported (Khanna et al., 2003). Parallel swabbing of the
ocular tear ﬁlms at day 3 following the induction of sodium butyrate
failed to reveal any virus in treated or untreated mice (data not
shown).We did not detect any ﬂuorescence in uninfected but sodium
butyrate-treated mice (Fig. 10D) nor in latently infected untreated
mice (Fig. 10C). While vehicle (phosphate buffered saline; PBS)-
treated latently infected mice controls were not performed in this
work, parallel studies have indicated that PBS injection alone does
not have any effects on latent genome copy number (unpublished
observations). Fluorescent gene expression is not detectable in daymicroscopy. Supernatant ﬂuid from reactivated ex vivo cultures of TG infected with pgB/
at the indicated times. Magniﬁcation, 20×; BF, brightﬁeld; Fluor, ﬂuorescence.
Fig. 10. Detection of in situ promoter activity inwhole ﬁxed TG tissue by confocal microscopy. TG were excised frommice at the indicated days post-infection (d.p.i), ﬁxed and mounted onto
glass slides prior to imaging by confocal microscopy. A and D) non-infected; B) acute infection (4 d.p.i); C, E, F) latent infection (N35 d.p.i). C–F) Some of the non-infected and latently infected
mice were treated with 1200 mg/kg sodium butyrate (NaB) 3 days before TG excision. F) Zoomed image of a single neuron showing both EGFP and RFP expressions. Magniﬁcation 60×.
260 S. Ramachandran et al. / Virology 378 (2008) 254–26415 infected TG (data not shown). As such, the dual ﬂuorescence seen
in latently infected sodium butyrate-treated animals suggests that
viral gene expression of both γ1 and γ2 classes in the TG reﬂectsreactivation from latency. Virus is not seen at the periphery
indicating that lytic gene expression can occur without necessarily
resulting in virus delivery to the periphery. This is consistent with
261S. Ramachandran et al. / Virology 378 (2008) 254–264recent models suggesting there is immune control of reactivation and
peripheral virus delivery following onset of lytic gene expression from
the latent state.
Discussion
The advancement of ﬂuorescence imaging equipment combined
with the availability of genes encoding proteins that ﬂuoresce at
different wavelengths has greatly enhanced our ability to visualize
gene expression in situ. In previous studies, we developed single
ﬂuorescent viruses under the ICP0 or gC promoters to examine acute
infection in mice as well as reactivation from latency (Decman et al.,
2005b). Another group has also developed a recombinant ﬂuorescent
HSV-1 to study acute infection and reactivation (Balliet et al., 2007).
However, in this virus, EGFP is expressed from the human
cytomegalovirus major immediate early promoter (HCMV-MIEP)
and not an HSV-1 promoter, so EGFP could be expressed con-
stitutively and in the absence of reactivation-induced HSV-1-speciﬁc
transactivators. Here we describe the construction and characteriza-
tion of a recombinant HSV-1 that expresses EGFP and RFP from
different kinetic classes of HSV-1 promoters. To our knowledge, the
use of recombinant HSV-1 to simultaneously visualize expression of
two or more genes within a single cell in the context of HSV-1
promoters has not been explored. This dual ﬂuorescent reporter
virus demonstrated the expected kinetics of both EGFP and RFP RNA
transcription and protein expression regulated by the native
promoters for gB and gC, respectively. The virus had growth
phenotypes indistinguishable from wild type HSV-1 RE in mice,
including parameters of acute corneal growth, acute TG replication,
as well as establishment of and reactivation from latency. Impor-
tantly, we show that latency was associated with a CD8+ T cell
immune inﬁltrate that was equivalent to that seen in TG latently
infected with wild type virus. Further, we detected no CD8+ T cell
reactivity to the ﬂuorescent proteins, EGFP or RFP. The ﬂuorescent
reporters allowed rapid visualization and quantiﬁcation of reactiva-
tion events following TG explant. We were able to routinely detect
expression of both the γ1 EGFP gene and the γ2 RFP gene at four days
post-explant by lowmagniﬁcation screening.While this is somewhat
longer than that needed to detect reactivation by plaque assay for
virus in the supernatant, it enables a rapid visual identiﬁcation of
reactivating γ2 gene expressing neurons in real time. Scanning at
higher magniﬁcations increases sensitivity of detection so that γ2
gene expression can be seen at earlier time points, but it is more
time-consuming and prolonged exposure of the cultures to UV light
may alter physiological conditions to the detriment of the culture.
The longer maturation time for RFP may also contribute to the delay.
However, the ﬂuorescent gene expression allowed us to demonstrate
multiple reactivation events in situ in ganglia of latently infected
mice treated with sodium butyrate to induce reactivation.
The use of ﬂuorescence to identify viral reactivation in ex vivo
cultures of latently infected TG saves both time and resources com-
pared to using standard viral plaque assays, and it enables dynamic
studies of reactivation events ex vivo. The impetus for this work was
the challenging issues surrounding the dynamic analysis of the
expression of multiple viral genes at the single-cell level, especially
during reactivation from latency. There are no other simple,
reproducible and sensitive assays for such analyses. The widely
used approach of in situ hybridization (ISH) and/or PCR to address
RNA expression, and/or immunohistochemistry (IHC) to identify
protein synthesis (Sawtell, 1997; Sawtell et al., 1998) suffer from
practical and dynamic limitations. While ISH, PCR and IHC
approaches enable identiﬁcation of gene expression events at the
single-cell level, they require time-consuming visual inspection of
hundreds of sections per ganglia at any one time point and highly
speciﬁc immunological reagents to enable protein detection.
Analyses of two proteins expressed by the same cell requires eithercomplex staining schemes or serial sectioning and identiﬁcation by
different antibodies, followed by location of the same cell in
subsequent sections, which can be difﬁcult. The dual ﬂuorescent
approach with a virus such as that detailed here allows expression
from two viral promoters to be easily visualized at the single-cell
level in a dynamic fashion.
Several reporter genes, including β-galactosidase and luciferase,
have been used to assess gene expression during the various stages of
HSV-1 latency (Margolis et al., 1992). The use of β-galactosidase has
the disadvantage that its detection requires ﬁxation and treatment
with substrate compounds for detection. While whole organs can be
analyzed, it is also a static assay. It has also been suggested that β-
galactosidase is quite stable and can be detected for long periods after
transcription is halted in the TG, possibly leading to the errant
conclusion that transcription is ongoing (Margolis et al., 1992).
Following corneal infection with our recombinant virus, expression
of EGFP and RFP drastically decreased from 4 to 15 d.p.i. The rapid loss
of EGFP and RFP detection renders these reporters more accurate for
detection of ongoing viral gene expression.
Use of luciferase in conjunction with image visualization and
infrared spectroscopy (IVIS) system has enabled dynamic parameters
of infection to be addressed, but this technology has not yet enabled
activity to be correlated at the single-cell level. The pgB/pgC virus
enabled easy and dynamic examination of viral gene expression in
single-cell suspensions of dissociated TG in ex vivo cultures. The dual
ﬂuorescence is an extension of our previous studies in which single
ﬂuorescent viruses were used to show that IFN-γ, a CD8+ Tcell effector
molecule, can block HSV-1 reactivation. IFN-γ inhibited reactivation in
part by blocking expression of the ICP0 α gene, which is required for
efﬁcient reactivation of HSV-1 from latency (Halford and Schaffer,
2001), and also by blocking a late step following expression of the gC
γ2 gene (Decman et al., 2005b). However, these studies required
infecting different mice with the different recombinant viruses. The
virus described herein permits such an analysis examining expression
of two different temporally regulated genes within single neurons of
the same ganglia from the same infected mouse. HSV-speciﬁc CD8+ T
cells were shown to block HSV-1 reactivation prior to expression of gC
(Liu et al., 2000b). This virus will allow a more deﬁnitive investigation
of the step in the viral life cycle at which CD8+ Tcells block reactivation
from latency in neurons.
The pgB/pgC virus is an extremely valuable tool in studying various
aspects of HSV-1 latency and reactivation as the ﬂuorescent proteins
are expressed from different HSV-1 promoters. This virus has ap-
plications in molecular virology and viral immunology and may lead
to a better understanding of HSV-1 latency and reactivation both in
vivo and in ex vivo experiments.
Materials and methods
Cells and viruses
Vero cells (ATCC, Manassas, Virginia) and B6WT3 cells (ATCC) were
grown in Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented
with 10% fetal bovine serum (FBS), Penicillin-G (100 units/ml),
Streptomycin (100 mg/ml) and Fungizone (250 mg/ml). The RE strain
of HSV-1 (HSV-1 RE) was used as the basis for all viruses.
Construction of recombinant HSV-1
The recombinant virus generated for this study RE-pgB-EGFP/
pgC-RFP (pgB/pgC) was derived on the HSV-1 RE background and is a
null mutant for the non-essential gC gene. Cloning was based on a
previously detailed plasmid that contained the gC promoter driving
expression of EGFP, followed by part of the gC ORF (Decman et al.,
2005b). This contained an NheI/XbaI fragment of EGFP obtained from
the plasmid EGFP-N1 expressed in frame with the eighth amino acid
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500 bp DNA fragment of the gB promoter was generated by PCR
ampliﬁcation from HSV-1 RE DNA using primers and the proof-
reading polymerase Expand (Roche, Indianapolis, IN) to amplify
sequences from immediately upstream of the gB initiating ATG to
a position 500 bp upstream (Forward 5′-GGGATCCGTCGTGCCCCCC-
GTCAGGTAGC-3′ and Reverse, 5′-GGGAAGCTTTGACGAAGC-
GGTCGTTGGCCAGCCT-3′). The primers were designed to add
unique HindIII and BamHI sites to the distal and proximal ends,
respectively, to facilitate cloning into unique HindIII and BamHI sites
inside the polylinker sequences immediately N-terminal to the EGFP
gene in pgC-EGFP, to give pgC-pgB-EGFP. The second ﬂuorescent
gene, RFP was PCR ampliﬁed using mRFP-N1 with primers that added
ﬂanking NheI sites to facilitate in-frame cloning into the unique NheI
site downstream of the gC promoter in the pgC-pgB-EGFP plasmid.
The ﬁnal plasmid, pgC-RFP/pgB-EGFP, contains the gC promoter
driving mRFP followed by the gB promoter driving EGFP. HSV-1 RE
infectious DNA was co-transfected with SspI linearized pgC-RFP/pgB-
EGFP into Vero cells, using Lipofectamine 2000 (Invitrogen, Carlsbad,
CA) as per the manufacturer's instructions. Homologous recombina-
tion between the ﬂanking gC promoter and the gC coding sequences
enabled insertion of the dual ﬂuorescent cassette into the gC locus.
Fluorescent progeny plaques were identiﬁed by microscopy under
short-term exposure to a xenon lamp, with excitation narrowed to
the peak range of excitation of RFP and subjected to several rounds of
plaque puriﬁcation until pure. The correct insertion of the cassette
into the virus as well as genetic purity was conﬁrmed by Southern
blotting and by absence of expression of gC protein, using a
commercial speciﬁc antibody to gC (Virusys, Skykesville, MD).
Puriﬁed virus was obtained from Vero cells using OptiPrep®
gradients, according to the manufacturer's instructions (Accurate
Chemical and Scientiﬁc Corp., Westbury, NY). Puriﬁed virus was
aliquoted, stored at −80 °C and quantiﬁed on Vero cell monolayers.
Analysis of HSV-1 protein expression
Subconﬂuent Vero cell monolayers were infected with either HSV-
1 RE or pgB/pgC at an MOI of 10 PFU/cell for 1 h at room temperature
(25 °C) in media lacking or containing 150 μg/ml of cycloheximide
(CHX; Sigma-Aldrich, St. Louis, MO) or 350 μg/ml phosphonoacetic
acid (PAA; Lancaster Synthesis, Pelham, NH). Following media
replacement under the same conditions, the monolayers were in-
cubated at 37 °C. CHX-reversal studies were performed at 6 h post-
media change as previously detailed (Honess and Roizman, 1974).
Brieﬂy, cells were washed three times with media lacking cyclohex-
imide but containing 15 μg/ml actinomycin-D (AD; Sigma-Aldrich).
Cells were incubated for further 2 h in media with AD prior to
harvesting. Infected cells incubated in media buffered PAA to block
DNA replication were harvested at 12 h post-infection. Cells were
harvested by washing in ice-cold PBS and the proteins solubilized in
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS
PAGE) buffer, boiled, and separated by SDS PAGE. Proteins were
detected by staining, or were transferred to Immobilon-P membranes
(Millipore, Billerica, MA) for immunoblot analyses. Antibodies to EGFP
(Afﬁnity Bioreagents, Golden, CO), RFP (Becton-Dickinson, Franklin
Lakes, NJ), gB and gC (Virusys) were detected using horseradish
peroxidase and West Dura chemiluminescent reagents (Pierce
Biotechnology Inc., Rockford, IL), as detailed previously (Eisfeld et al.,
2006).
Analysis of HSV-1 RNA transcription
Subconﬂuent Vero cell monolayers were infected with pgB/pgC at
an MOI of 10 PFU/cell for 1 h at room temperature (25 °C) in normal
media or media containing 350 μg/ml PAA. Following media
replacement under the same conditions, the monolayers were in-cubated at 37 °C. Cells were harvested at 6, 8 and 12 h post-infection
and whole cell RNA was extracted using the RNeasy Midi Kit (Qiagen,
Valencia, CA). RNA samples containing formamide were run on a 1%
agarose gel containing formaldehyde, and then transferred to
positively charged nylon membrane (Genescreen, Perkin Elmer,
Boston, MA). Identical blots were probed for EGFP using a 900 bp
fragment from a NheI/BglII restriction digest of EGFP-C3 and for RFP,
an 850 bp fragment from NheI/HindIII digest of RFP. Probes were
labeled using random primer labeling extension with the incorpora-
tion using dCTP-[α-32P] (3000 Ci/mmol: Perkin Elmer). Autoradio-
graphs exposed to be in the linear range of the ﬁlm were then
quantiﬁed using MetaMorph software.
Multistep in vitro growth kinetics
Vero cells were infected at an MOI of 0.01 PFU/cell, and incubated
as stated in the text for different times. Cells and supernatants were
combined for harvest, and infectious virus released following three
freeze–thaw cycles was detected by standard plaque assay.
Mice and ocular infections
Three to ﬁve-week old female wild type C57BL/6 (Jackson
Laboratories, Bar Harbor, ME) were anesthetized by the intraperito-
neal injection of 2.0 mg of ketamine hydrochloride and 0.04 mg of
xylazine (Phoenix Scientiﬁc, St. Joseph, MO) in 0.2 ml of Hanks
buffered salt solution (BioWhittaker, Walkersville, MD). Both corneas
were scariﬁed and infected topically with puriﬁed HSV-1 viruses at
1×105 105 PFU/eye in 3 μl of RPMI (BioWhittaker). All animal studies
were carried out under University of Pittsburgh IACUC approved
protocols in AALAAC approved facilities and in accordance with the
ethical treatment of animals, as deﬁned by the ARVO Statement for the
Use of Animals in Ophthalmic and Vision research.
Viral replication and spread
Viral replication in the eye was determined in tear ﬁlm samples
obtained using a foam-tipped applicator. The foam tips were
transferred to DMEM, vortexed and virus titrated on Vero cells by a
standard plaque assay. To determine viral titers in the ganglia, TGwere
surgically excised at 4 and 8 days post-infection (d.p.i) from
euthanized animals, homogenized using trituration and subjected to
three freeze–thaw cycles prior to titration on Vero cells.
Single-cell TG suspensions and ﬂow cytometry
At the indicated times after infection, mice were euthanized by
exsanguination. TG were excised, resuspended in DMEM containing
10% FBS and 400 U/ml collagenase Type 1 (Sigma-Aldrich) per TG for
1 h at 37 °C. Cells were then dissociated into single-cell suspensions by
trituration. Single-cell TG suspensions were stained for ﬂow cyto-
metric analysis as previously described (Freeman et al., 2007).
Fluorochrome-conjugated Abs against CD8α (clone 53-6.7), CD45
(clone 30-F11), IFN-γ (clone XMG1.2) and the proper isotype control
Abs were purchased from BD Pharmingen (San Diego, CA). PE-
conjugated H-2Kb/gB498–505 (SSIEFARL) tetramers (Tetramer Core
Facility, NIAID, NIH) or biotinylated H-2Kb/gB498–505 monomers
(Tetramer Core Facility, NIAID, NIH) conjugated to streptavidin-
bound Qdots (Invitrogen) at a molar ratio of 1:1 were used to identify
the H-2Kb-restricted HSV-1 gB498–505-speciﬁc CD8+ T cell population.
T cell stimulation assay
At 8 d.p.i, TG were excised and dissociated into single-cell
suspensions by treatment with collagenase type I as just described.
One-half TG equivalent of cells were then combined and with 5×105
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EGFP (EGFP-N1), RFP (mRFP-1), glycoprotein B (pPEP98) or untreated
cells. Incubation was in the presence of GolgiPlug™ (BD Biosciences).
Following a 6 h stimulation at 37 °C, cells were ﬁxed with 4%
paraformaldehyde and surface stained using ﬂuorochrome-conju-
gated antibodies against CD8α and CD45, as described above. The cells
were then permeabilized using Cytoﬁx/Cytoperm (BD) and stained for
intracellular IFN-γ prior to ﬂow cytometric analysis.
Quantitative real-time PCR
HSV-1 genome copy number in HSV-1-infected TG was deter-
mined by quantitative real-time PCR as previously described (Freeman
et al., 2007).
Ex vivo TG cultures
Single-cell TG suspensions were plated at one-ﬁfth TG equivalents
per well in 48-well culture plates in 400 μl of DMEM containing 10%
FBS, 10 mM HEPES buffer (GIBCO), 10 U/ml recombinant murine IL-2
(R and D Systems), and 50 μM2-mercaptoethanol. Cultures of TGwere
monitored for reactivation in two ways. First, virus production was
assessed by testing culture supernatant ﬂuid for live virus by standard
viral plaque assays as previously described (Liu et al., 2000a). Cultures
of TG infected with pgB/pgC were further monitored for virus
production by observing the wells under a ﬂuorescence microscope
at low magniﬁcation (2× objective) for expression of EGFP and RFP in
neurons and spread to surrounding ﬁbroblasts. Scanning for ﬂuores-
cence was performed at lowmagniﬁcation to minimize the amount of
time the cultures were exposed to uncontrolled conditions outside of
the 37 °C, 5% CO2 incubator, and to minimize UV exposure. Each
assessment was conducted every two days for a total of ten days in
culture. Data are represented as the percent of wells that were positive
for viral reactivation, and statistics were calculated using survival
curve analysis (Log-rank test) with the GraphPad Prism software
package.
In vivo induction of reactivation
Latently infected mice (33 d.p.i) were treated with a single
intraperitoneal injection of 1200 mg/kg of sodium butyrate in PBS
(ﬁnal volume, 100 μl) (Neumann et al., 2007). TG for confocal imaging
were harvested 3 days post-injection as described below.
Confocal imaging of undissociated TG mounts
Mice were euthanized on days 4, 15, 35 or 36 post-infection by
cardiac perfusion, using freshly made ﬁxative containing sodium m-
periodate (0.001 M), lysine (0.075 M) and paraformaldehyde (1%) in
0.1 M Phosphate buffer. TG were excised and further incubated
overnight in the same ﬁxative at 4 °C in round bottom 96-well plates.
Fixed TG were then squash mounted onto glass slides with Aqua-
mount and imaged using confocal microscopy (Olympus).
Acknowledgments
This work was supported by EY015291 (PRK) and EY EY05945 (RLH),
as well as a CORE grant for vision research EY08098, funds from the Eye
andEar Institute of Pittsburghand fromtheResearch toPreventBlindness
Inc. The authors gratefully acknowledge the technical assistance of P.
Nassman, V. Imbrogno, Jean-Paul Vergnes and Kira Lathrop.
References
Amelio, A.L., McAnany, P.K., Bloom, D.C., 2006. A chromatin insulator-like element in the
herpes simplex virus type 1 latency-associated transcript region binds CCCTC-binding factor and displays enhancer-blocking and silencing activities. J. Virol. 80
(5), 2358–2368.
Balliet, J.W., Kushnir, A.S., Schaffer, P.A., 2007. Construction and characterization of a
herpes simplex virus type I recombinant expressing green ﬂuorescent protein:
acute phase replication and reactivation in mice. Virology 361 (2), 372–383.
Decman, V., Freeman, M.L., Kinchington, P.R., Hendricks, R.L., 2005a. Immune control of
HSV-1 latency. Viral Immunol. 18 (3), 466–473.
Decman, V., Kinchington, P.R., Harvey, S.A.K., Hendricks, R.L., 2005b. Gamma interferon
can block herpes simplex virus type 1 reactivation from latency, even in the
presence of late gene expression. J. Virol. 79 (16), 10339–10347.
Eisfeld, A.J., Turse, S.E., Jackson, S.A., Lerner, E.C., Kinchington, P.R., 2006.
Phosphorylation of the varicella-zoster virus (VZV) major transcriptional
regulatory protein IE62 by the VZV open reading frame 66 protein kinase. J.
Virol. 80 (4), 1710–1723.
Feldman, L.T., Ellison, A.R., Voytek, C.C., Yang, L., Krause, P., Margolis, T.P., 2002.
Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice.
Proc. Natl. Acad. Sci. 99 (2), 978–983.
Freeman, M.L., Sheridan, B.S., Bonneau, R.H., Hendricks, R.L., 2007. Psychological stress
compromises CD8+ T cell control of latent herpes simplex virus type 1 infections. J.
Immunol. 179 (1), 322–328.
Gambotto, A., V Cicinnati, G.D., Kenniston, T., Steitz, J., Tüting, T., Robbins, P.D., DeLeo, A.B.,
2000. Immunogenicity of enhanced green ﬂuorescent protein (EGFP) in BALB/c mice:
identiﬁcation of an H2-Kd-restricted CTL epitope. Gene Therapy 23 (7), 2036–2040.
Halford, W.P., Schaffer, P.A., 2001. ICP0 is required for efﬁcient reactivation of herpes
simplex virus type 1 from neuronal latency. J. Virol. 75 (7), 3240–3249.
Hendricks, R.L., Weber, P.C., Taylor, J.L., Koumbis, A., Tumpey, T.M., Glorioso, J.C., 1991.
Endogenously produced interferon {alpha} protects mice fromherpes simplex virus
type 1 corneal disease. J. Gen. Virol. 72 (7), 1601–1610.
Honess, R.W., Roizman, B., 1974. Regulation of herpesvirus macromolecular synthesis I.
Cascade regulation of the synthesis of three groups of viral proteins. J. Virol.14 (1), 8–19.
Hoshino, Y., Pesnicak, L., Cohen, J.I., Straus, S.E., 2007. Rates of reactivation of latent
herpes simplex virus frommouse trigeminal ganglia ex vivo correlate directly with
the viral load and inversely with the number of inﬁltrating CD8+T cells. J. Virol.
07–00474 JVI.
Hufner, K., Derfuss, T., Herberger, S., Sunami, K., Russell, S., Sinicina, I., Arbusow, V.,
Strupp, M., Brandt, T., Theil, D., 2006. Latency of alpha-herpes viruses is
accompanied by a chronic inﬂammation in human trigeminal ganglia but not in
dorsal root ganglia. J. Neuropathol. Exp. Neurol. 65 (10), 1022–1030.
Khanna, K.M., Bonneau, R.H., Kinchington, P.R., Hendricks, R.L., 2003. Herpes simplex
virus-speciﬁc memory CD8+ T cells are selectively activated and retained in latently
infected sensory ganglia. Immunity 18 (5), 593–603.
Kodukula, P., Liu, T., Rooijen, N.V., Jager, M.J., Hendricks, R.L., 1999. Macrophage control
of herpes simplex virus type 1 replication in the peripheral nervous system. J.
Immuno.l 162 (5), 2895–2905.
Kramer, M.F., Coen, D.M., 1995. Quantiﬁcation of transcripts from the ICP4 and
thymidine kinase genes in mouse ganglia latently infected with herpes simplex
virus. J. Virol. 69 (3), 1389–1399.
Lachmann, R.H., Efstathiou, S., 1997. Utilization of the herpes simplex virus type 1
latency-associated regulatory region to drive stable reporter gene expression in the
nervous system. J. Virol. 71 (4), 3197–3207.
Liu, T., Khanna, K.M., Chen, X., Fink, D.J., Hendricks, R.L., 2000a. CD8(+) T cells can block
herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J.
Exp. Med. 191 (9), 1459–1466.
Liu, T., Khanna, K.M., Chen, X., Fink, D.J., Hendricks, R.L., 2000b. CD8+ T cells can block
herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J.
Exp. Med. 191 (9), 1459–1466.
Lubinski, J.M., Jiang, M., Hook, L., Chang, Y., Sarver, C., Mastellos, D., Lambris, J.D., Cohen,
G.H., Eisenberg, R.J., Friedman, H.M., 2002. Herpes simplex virus type 1 evades the
effects of antibody and complement in vivo. J. Virol. 76 (18), 9232–9241.
Luker, G.D., Bardill, J.P., Prior, J.L., Pica, C.M., Piwnica-Worms, D., Leib, D.A., 2002.
Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and
therapy in living mice. J. Virol. 76 (23), 12149–12161.
Margolis, T.P., Sedarati, F., Dobson, A.T., Feldman, L.T., Stevens, J.G., 1992. Pathways of
viral gene expression during acute neuronal infection with HSV-1. Virology 189 (1),
150–160.
Margolis, T.P., Elfman, F.L., Leib, D., Pakpour, N., Apakupakul, K., Imai, Y., Voytek, C., 2007.
Spontaneous reactivation of HSV-1 in latently infected murine sensory ganglia. J.
Virol. 07–00243 JVI.
Mueller, S.N., Jones, C.M., Chen, W., Kawaoka, Y., Castrucci, M.R., Heath, W.R., Carbone,
F.R., 2003. The early expression of glycoprotein B from herpes simplex virus can be
detected by antigen-speciﬁc CD8+ T cells. J. Virol. 77 (4), 2445–2451.
Neumann, D.M., Bhattacharjee, P.S., Hill, J.M., 2007. Sodium butyrate: a chemical
inducer of in vivo reactivation of herpes simplex virus type 1 in the ocular mouse
model. J. Virol. 81 (11), 6106–6110.
Orr, M.T., Mathis, M.A., Lagunoff, M., Sacks, J.A., Wilson, C.B., 2007. CD8 T cell control of
HSV reactivation from latency is abrogated by viral inhibition of MHC class I. Cell
Host Microbe 2 (3), 172–180.
Sawtell, N.M., 1997. Comprehensive quantiﬁcation of herpes simplex virus latency at the
single-cell level. J. Virol. 71 (7), 5423–5431.
Sawtell, N.M., Poon, D.K., Tansky, C.S., Thompson, R.L., 1998. The latent herpes simplex
virus type 1 genome copy number in individual neurons is virus strain speciﬁc and
correlates with reactivation. J. Virol. 72 (7), 5343–5350.
Tal-Singer, R., Lasner, T.M., Podrzucki, W., Skokotas, A., Leary, J.J., Berger, S.L., Fraser,
N.W., 1997. Gene expression during reactivation of herpes simplex virus type 1
from latency in the peripheral nervous system is different from that during lytic
infection of tissue cultures. J. Virol. 71 (7), 5268–5276.
264 S. Ramachandran et al. / Virology 378 (2008) 254–264Theil, D., Derfuss, T., Paripovic, I., Herberger, S., Meinl, E., Schueler, O., Strupp, M.,
Arbusow, V., Brandt, T., 2003. Latent herpesvirus infection in human trigeminal
ganglia causes chronic immune response. Am. J. Pathol. 163 (6), 2179–2184.
Verjans, G.M., Hintzen, R.Q., van Dun, J.M., Poot, A., Milikan, J.C., Laman, J.D., Langerak,
A.W., Kinchington, P.R., Osterhaus, A.D., 2007. Selective retention of herpes simplex
virus-speciﬁc T cells in latently infected human trigeminal ganglia. Proc. Natl. Acad.
Sci. U. S. A. 104 (9), 3496–3501.Wang, Q.-Y., Zhou, C., Johnson, K.E., Colgrove, R.C., Coen, D.M., Knipe, D.M., 2005.
Herpesviral latency-associated transcript gene promotes assembly of heterochro-
matin on viral lytic-gene promoters in latent infection. Proc. Natl. Acad. Sci. 102
(44), 16055–16059.
Zarling, J.M.,Moran, P.A., Burke, R.L., Pachl, C., Berman, P.W., Lasky, L.A.,1986. Human cytotoxic
T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and
activation by cloned glycoproteins gB and gD. J. Immunol. 136 (12), 4669–4673.
